As a result, a strategy to increase Treg by targeting Sirt1 has been exploited in various preclinical models of autoimmunity and inflammatory disorders and found that Sirt1 could be used as an essential target to improve Treg numbers and their suppressive activity [100,113,118]. The gene discussed is SIRT1; the disease is Autoimmunity.